GLP-1 Weight Loss Medication (Semaglutide)

Semaglutide is a GLP-1 receptor agonist, a medicine that mimics a gut hormone. It slows stomach emptying, reduces appetite and improves blood sugar control. It is given as a weekly injection under the skin; tirzepatide is a related drug acting on two hormones. Both are licensed for type 2 diabetes and, at higher doses, for weight management.

In trials, people lost on average about 15 percent of body weight over roughly a year on semaglutide with lifestyle support, and somewhat more on tirzepatide. Weight tends to return when the drug is stopped, so it is long-term treatment, not a course.

What GLP-1 Weight Loss Medication (Semaglutide) involves

Treatment starts with a medical assessment: weight history, body mass index, blood pressure, blood tests for glucose, HbA1c, kidney, liver and thyroid function and lipids, and a review of your medicines. If you qualify, you are taught to inject with a pen device into the abdomen, thigh or upper arm once a week. The dose starts low and is stepped up every 4 weeks over about 4 to 5 months to limit nausea. A dietitian sets protein and fluid targets, and resistance exercise is advised to protect muscle. Review visits check weight, side effects and blood results, and the dose is held or reduced if you are not tolerating it. Diabetes medicines such as insulin or sulfonylureas may need lowering to avoid low blood sugar.

Who is a good candidate for GLP-1 Weight Loss Medication (Semaglutide)?

Prescribing follows licensed criteria and is a doctor's decision after assessment, not something to buy off the shelf.

• Body mass index of 30 or more
• Body mass index of 27 or more with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea
• People preparing for or regaining weight after bariatric surgery
• Those able to commit to long-term treatment and follow-up with a doctor at home

Es ist normalerweise nicht die richtige Wahl, wenn:

• Pregnancy, breastfeeding, or planning pregnancy within 2 months
• Personal or family history of medullary thyroid cancer or MEN2 syndrome
• Previous pancreatitis, or severe gastroparesis
• People of normal weight seeking cosmetic slimming
• Active eating disorder

Technikoptionen

• Semaglutide weekly injection: The most widely used; doses for weight management are higher than those for diabetes.
• Tirzepatide weekly injection: Dual GIP and GLP-1 action; greater average weight loss in trials.
• Liraglutide daily injection: Older option with smaller effect.
• Oral semaglutide: Tablet form licensed for diabetes; convenient but with strict dosing rules.
• Bariatric surgery: Still produces larger and more durable weight loss at higher body mass index; medication and surgery can be combined.

Was passiert während Ihrer Behandlung

The first visit takes about an hour including blood tests and teaching. The injection itself takes seconds and the needle is very fine. In the first weeks of each dose step, nausea, fullness, burping, constipation or loose stools are common and usually settle. Eating smaller, slower meals helps.

Vorbereitung auf Ihre Reise

This is ongoing treatment, so it is a poor reason to travel on its own. A visit can provide assessment, a start under supervision and a written plan, but you need a prescriber at home for monthly dose steps, repeat prescriptions and monitoring. Do not carry more pens than your home country's import rules allow, and keep them refrigerated.

• Informieren Sie den Arzt über Medikamente, Allergien, Schwangerschaft oder Stillen und eine Vorgeschichte von Fieberbläschen, Keloidnarben oder Autoimmunerkrankungen
• Vermeiden Sie Alkohol, Aspirin und entzündungshemmende Schmerzmittel für ein paar Tage im Voraus, wenn Ihr eigener Arzt zustimmt, um Blutergüsse zu reduzieren
• Kommen Sie ohne Make-up auf dem Behandlungsbereich an und vermeiden Sie zwei Wochen vorher Sonnenliegen und starke Sonne

Genesung und Ergebnisse

There is no downtime. Weight loss is gradual, usually 0.5 to 1 kilogram a week at first, reaching a plateau after 12 to 18 months. Reviews are typically monthly during dose increases and every 3 months afterwards. If less than about 5 percent of weight is lost after 3 months on a full dose, continuing is usually not worthwhile.

• Zurück zur alltäglichen Aktivität: Keine
• When results show: Within 4 to 8 weeks
• How long they last: While treatment continues

Sicherheit, Risiken und Revisionspolitik

Side effects are mostly digestive, but a few rare ones matter.

• Nausea, vomiting, constipation or diarrhoea, especially after dose increases
• Gallstones and gallbladder inflammation linked to rapid weight loss
• Pancreatitis, rare: stop the drug and seek care for severe persistent abdominal pain
• Loss of muscle mass along with fat if protein and exercise are neglected
• Low blood sugar when combined with insulin or sulfonylureas
• Worsening of diabetic eye disease with fast glucose lowering
• Counterfeit or compounded products of unknown content bought outside pharmacies

Jeder schriftliche Vorschlag wird durch Clinic-Y gibt an, was die Klinik abdeckt, wenn eine Korrektur erforderlich ist. Fragen Sie danach, bevor Sie buchen, nicht danach.

Cost of GLP-1 Weight Loss Medication (Semaglutide) in Türkiye

Clinic-Y does not publish a single price for GLP-1 Weight Loss Medication (Semaglutide), because the honest figure depends on your case. What moves it:

• Which drug and dose you reach, as higher doses cost more
• How many months of treatment you plan, realistically years
• Blood tests and follow-up consultations
• Dietitian and exercise support
• Local availability, which has been affected by supply shortages

Senden Sie Ihre Fotos oder Berichte und Sie erhalten geschrieben, All-inclusive Vorschläge von geeigneten Teams, Seite an Seite. Die Überprüfung Ihres Falls ist kostenlos.

Häufig gestellte Fragen